Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. (SRPT) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
326 institutional managers reported holding SRPT in 13F filings for the quarter ended 2026-03-31. Together they hold about 84% of the company; the top 10 hold 50%. 37 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 25.2M shares were sold short as of the 2026-06-15 count, about 21% of shares outstanding (9.1 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
SRPT's share count grew 30.6% over the past five years even with $25.01M spent on repurchases. It pays no dividend. Cash returned over the past three years: $25.01M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at SRPT over the trailing three years: 2023: 12 buys totaling $13.30M; 2024: 3 buys totaling $4.96M. 15 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
SRPT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2021-03-02 | +6.1% | -16.8% |
| 2021-05-06 | +4.5% | -2.2% |
| 2021-11-04 | +1.4% | -0.1% |
| 2022-03-02 | -10.7% | -8.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
SRPT's latest 8-K filings: 2026-08-05 (items 2.02, 9.01); 2026-07-27 (items 5.02, 7.01, 9.01); 2026-06-04 (items 5.02, 5.07, 9.01); 2026-05-06 (items 2.02, 9.01); 2026-02-25 (items 5.02).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 11, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.